William Grossman
Director; Director, Interim Chief Medical Officer · 3 filings · Latest: Sep 22, 2026
Day One Biopharmaceuticals, Inc.
enGene Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ENGN | William Grossman | Director, Interim Chief Medical Officer | Sep 22, 2026 | Purchase | $1.97 | 5,102 | $10.1K | 5,102 |